Why the study?
CKD and LV dysfunction are risk factors for cardiovascular events, but whether the association of LVEF with cardiac arrest, heart failure hospitalization, and mortality differs across stages of kidney impairment was unexplored.
Does the association of LVEF with cardiac arrest and heart failure hospitalization differ according to baseline eGFR in patients without ESKD?
Does the association of LVEF with cardiac arrest and heart failure hospitalization differ according to baseline eGFR in patients without ESKD?
Answers are grounded in this paper and cite their sources.
In patients with CKD but not ESKD, the protective association of higher LVEF against cardiac arrest and heart failure hospitalization is attenuated at lower levels of kidney function.
Introduction Chronic kidney disease (CKD) and left ventricular (LV) dysfunction are risk factors for cardiovascular events. We explore whether the association of LV ejection fraction (LVEF) with cardiac arrest, heart failure hospitalization, and all-cause mortality differs across stages of kidney impairment. Methods We performed an observational cohort study of 19,032 patients from 2004 to 2014 with estimated glomerular filtration rate (eGFR) ≤90 ml/min per 1.73 m 2 and without end-stage kidney disease (ESKD). Cox regression models, incorporating an interaction term for eGFR and LVEF, were fit and adjusted for relevant covariates. Results Mean age of the patients was 67 ± 14 years, and 51% were male. The mean eGFR was 64 ± 19 ml/min per 1.73 m 2 and LVEF was 54 ± 13%. Over a median follow-up of 3.0 (0.7–6.0) years there were 504 cardiac arrests, 4181 heart failure hospitalizations, and 6989 deaths. The association of LVEF with cardiac arrest and heart failure hospitalization differed according to continuous eGFR ( P -interaction <0.01 for both outcomes). The association of LVEF with cardiac arrest in the lowest quartile was attenuated (adjusted hazard ration [aHR] per 5% higher LVEF 0.92; 95% confidence interval [CI] 0.88–0.96) compared to the highest eGFR quartile (aHR per 5% higher LVEF 0.85; 95% CI 0.78–0.91). The association of LVEF with heart failure hospitalization was similarly attenuated in the lowest eGFR quartile. There was no effect modification of LVEF by continuous eGFR for all-cause mortality ( P -interaction 0.26). Conclusion Among non-ESKD patients with eGFR ≤90 ml/min per 1.73 m 2 , the association of LVEF with cardiac arrest and heart failure hospitalization is attenuated at lower levels of kidney function. Further research is required to elucidate what factors beyond LVEF drive these observations.
No takes yet. Share an insight, caveat, or question.
Ravi et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: